Real-life efficacy interstitial laser therapy treating laxity of the periorbital region

Abstract

Skin laxity in the periorbital region is a common problem that is usually treated surgically. This is not only invasive, but it also increases the risks for the patient and can result in scarring. Innovative therapies involving the use of the most recent generation of interstitial lasers allow for safe, minimally invasive, and effective intervention in patients suffering from blepharochalasis and periorbital bags. A 100% Made in Italy intra-tissue laser lifting technology, in particular, delivers energy to the subcutaneous tissue via laser fibers as small as 200/300 microns, ensuring a targeted release of energy and allowing the formation of new collagen while decreasing skin laxity. The purpose of this study is to assess the effect of an interstitial laser using optical microfibers on 5 patients aged 30 to 60 years. Following anesthesia (Lidocaine and Adrenaline), the treatment was performed using an endotissue laser with a wavelength of 1470 nm. The cumulative energy delivered by the laser by using 300-micron disposable fibers is equal to 200 Joules for each lid, with an infrared thermometer confirming an increase in skin temperature not exceeding 40°C. Over the next six months, patients experienced optimal results with no visible skin signs. In conclusion, we can state that intra-tissue laser lifting can be an effective strategy for the treatment of periorbital laxity, resulting in a decrease in dermal laxity and greater skin homogeneity while ensuring high precision, the absence of superficial incisions, rapid recovery, and optimal results.